| Cat.No. | Name | Information |
|---|---|---|
| M7325 | Rimonabant Hydrochloride | Rimonabant hydrochloride is a cannabinoid receptor antagonist, which binds selectively to central cannabinoid receptors (CB1) with high affinity |
| M45351 | Surinabant | Surinabant is a selective, high affinity, orally active cannabinoid receptor type 1 CB1R antagonist. |
| M45349 | PF-431499 | PF-431499 is a cannabinoid receptor CB1 antagonist for research related to endocrine and metabolic diseases. |
| M45346 | CXB-029 | CXB-029 is a cannabinoid receptor CB1 antagonist that can be used in studies related to glaucoma and obesity. |
| M45345 | CRB-913 | CRB-913 is a novel, orally active cannabinoid receptor CB1 inverse agonist for research related to endocrine and metabolic diseases. |
| M45344 | CP-741952 | CP-741952 is a cannabinoid receptor CB1 antagonist for research related to endocrine and metabolic diseases. |
| M45343 | BMS-812204 | BMS-812204 is a cannabinoid receptor CB1 antagonist for research related to endocrine and metabolic diseases. |
| M45342 | AZD-2207 | AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound that can be used in studies related to type 2 diabetic disease and obesity. |
| M45341 | Ajulemic acid | Ajulemic acid is a synthetic, orally available Δ9-tetrahydrocannabinol metabolite and cannabinoid receptor agonist with Ki values of 5.7 nM for hCB1 and 56.1 nM for hCB2, and EC50 values of 11.6 nM and 13.4 nM, respectively. |
| M45340 | WIN 55212-2 | WIN 55212-2 is a non-specific cannabinoid receptor agonist. |
| M45339 | CP 55940 | CP 55940 is a variant full agonist of the CB1 receptor that exhibits high and approximately equal affinity for central and peripheral cannabinoid receptors, with Ki's of 0.6 - 5.0 and 0.7-2.6 nM for CB1 and CB2, respectively, and EC50 values of 0.2 and 0.3 nM for CB1 and CB2, respectively.In addition, when acting on GRP55, the EC50 value is 5 nM. |
| M41793 | AM841 | AM841 is a high-affinity electrophilic ligand. |
| M41792 | CB2 PET Radioligand 1 | CB2 PET Radioligand 1 is a PET Radioligand targeting to hCB2 (Ki=7.7 nM). |
| M41791 | CB-25 | CB-25 is a ligand of CB1 cannabinoid receptors, acting as a partial agonist. |
| M41790 | O-2093 | O-2093 is a selective endocannabinoid anandamide (AEA) reuptake inhibitor with IC50 of 17.3 μM. |
| M41789 | Monlunabant | Monlunabant ( (S)-MRI-1891) is a solid dispersion compound that is also an orally active inhibitor of the cannabinoid CB1 receptor. |
| M41637 | CB1R/AMPK modulator 1 | CB1R/AMPK modulator 1 is an orally active CB1R/AMPK modulator, with an Ki of 0.81 nM and an IC50 of 3.9 nM for CB1R. |
| M40943 | INV-202 | INV-202 is an orally active type 1 cannabinoid receptor (CB1) blocker that blocks the receptor protein CB1 in peripheral tissues such as adipose tissue, gastrointestinal tract, kidneys, liver, pancreas, muscle, and lungs, and can be used in studies related to obesity. |
| M40564 | AEF0117 | AEF0117 is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi). |
| M31378 | Auriculasin | Auriculasin is a naturally occurring polyphenolic flavonoid that acts on cannabinoid receptor 1 (CB1) with an IC50 value of 8.92 µM. It is also a potential inhibitor of SOS1-KRAS interactions with anticancer and anti-inflammatory activities. |
| M30911 | CB2 receptor agonist 3 | CB2 receptor agonist 3 is a robust and selective CB2 cannabinoid agonist with Kis of 7.6 and 900 nM for CB2 and CB1, respectively. CB2 receptor agonist 3 significantly increases P-ERK 1/2 expression in HL-60 cells. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
